KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Accounts Payables (2016 - 2026)

Idexx Laboratories has reported Accounts Payables over the past 17 years, most recently at $110.4 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 3.33% year-over-year to $110.4 million; the TTM value through Dec 2025 reached $110.4 million, down 3.33%, while the annual FY2025 figure was $110.4 million, 3.33% down from the prior year.
  • Accounts Payables for Q4 2025 was $110.4 million at Idexx Laboratories, down from $122.3 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $127.3 million in Q2 2022 and troughed at $86.7 million in Q3 2021.
  • A 5-year average of $111.5 million and a median of $113.4 million in 2023 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: soared 55.77% in 2021 and later fell 15.4% in 2023.
  • Year by year, Accounts Payables stood at $116.1 million in 2021, then dropped by 5.1% to $110.2 million in 2022, then grew by 0.38% to $110.6 million in 2023, then increased by 3.22% to $114.2 million in 2024, then decreased by 3.33% to $110.4 million in 2025.
  • Business Quant data shows Accounts Payables for IDXX at $110.4 million in Q4 2025, $122.3 million in Q3 2025, and $116.6 million in Q2 2025.